Quest Diagnostics Incorporated (DGX)
USD 163.98
(0.08%)
USD 163.98
(0.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.26 Billion USD | -5.39% |
| 2022 | 1.42 Billion USD | -40.03% |
| 2021 | 2.38 Billion USD | 20.8% |
| 2020 | 1.97 Billion USD | 60.11% |
| 2019 | 1.23 Billion USD | 11.81% |
| 2018 | 1.1 Billion USD | -5.49% |
| 2017 | 1.16 Billion USD | -8.77% |
| 2016 | 1.27 Billion USD | -8.72% |
| 2015 | 1.39 Billion USD | 42.32% |
| 2014 | 983 Million USD | -33.36% |
| 2013 | 1.47 Billion USD | 22.83% |
| 2012 | 1.2 Billion USD | 20.68% |
| 2011 | 995 Million USD | -23.2% |
| 2010 | 1.29 Billion USD | -4.68% |
| 2009 | 1.35 Billion USD | 11.18% |
| 2008 | 1.22 Billion USD | 12.01% |
| 2007 | 1.09 Billion USD | -3.25% |
| 2006 | 1.12 Billion USD | 16.52% |
| 2005 | 968.11 Million USD | 7.4% |
| 2004 | 901.44 Million USD | 13.33% |
| 2003 | 795.43 Million USD | 34.26% |
| 2002 | 592.44 Million USD | 44.01% |
| 2001 | 411.39 Million USD | 29.44% |
| 2000 | 317.81 Million USD | 109.09% |
| 1999 | 152 Million USD | 61.19% |
| 1998 | 94.3 Million USD | 26.24% |
| 1997 | 74.7 Million USD | 112.42% |
| 1996 | -601.28 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 370 Million USD | 15.99% |
| 2024 Q1 | 319 Million USD | 2.57% |
| 2024 Q3 | 330 Million USD | -10.81% |
| 2023 Q2 | 348 Million USD | 14.1% |
| 2023 FY | 1.35 Billion USD | -5.39% |
| 2023 Q1 | 305 Million USD | 125.93% |
| 2023 Q3 | 342 Million USD | -1.72% |
| 2023 Q4 | 311 Million USD | -9.06% |
| 2022 Q4 | 135 Million USD | -65.56% |
| 2022 FY | 1.42 Billion USD | -40.03% |
| 2022 Q3 | 392 Million USD | 1.03% |
| 2022 Q2 | 388 Million USD | -24.37% |
| 2022 Q1 | 513 Million USD | -4.29% |
| 2021 FY | 2.38 Billion USD | 20.8% |
| 2021 Q1 | 660 Million USD | -16.98% |
| 2021 Q2 | 533 Million USD | -19.24% |
| 2021 Q3 | 652 Million USD | 22.33% |
| 2021 Q4 | 536 Million USD | -17.79% |
| 2020 Q4 | 795 Million USD | 10.72% |
| 2020 Q3 | 718 Million USD | 153.71% |
| 2020 Q2 | 283 Million USD | 61.71% |
| 2020 Q1 | 175 Million USD | -51.79% |
| 2020 FY | 1.97 Billion USD | 60.11% |
| 2019 FY | 1.23 Billion USD | 11.81% |
| 2019 Q1 | 248 Million USD | 12.73% |
| 2019 Q2 | 307 Million USD | 23.79% |
| 2019 Q4 | 363 Million USD | 15.97% |
| 2019 Q3 | 313 Million USD | 1.95% |
| 2018 Q3 | 304 Million USD | -0.33% |
| 2018 FY | 1.1 Billion USD | -5.49% |
| 2018 Q1 | 272 Million USD | 1.12% |
| 2018 Q2 | 305 Million USD | 12.13% |
| 2018 Q4 | 220 Million USD | -27.63% |
| 2017 Q4 | 269 Million USD | -9.73% |
| 2017 Q3 | 298 Million USD | -6.58% |
| 2017 FY | 1.16 Billion USD | -8.77% |
| 2017 Q2 | 319 Million USD | 14.34% |
| 2017 Q1 | 279 Million USD | 1.09% |
| 2016 Q3 | 322 Million USD | -23.7% |
| 2016 Q1 | 257 Million USD | 7.53% |
| 2016 FY | 1.27 Billion USD | -8.72% |
| 2016 Q4 | 276 Million USD | -14.29% |
| 2016 Q2 | 422 Million USD | 64.2% |
| 2015 Q1 | 228 Million USD | -11.28% |
| 2015 FY | 1.39 Billion USD | 42.32% |
| 2015 Q4 | 239 Million USD | -62.12% |
| 2015 Q3 | 631 Million USD | 109.63% |
| 2015 Q2 | 301 Million USD | 32.02% |
| 2014 Q3 | 256 Million USD | -2.29% |
| 2014 Q4 | 257 Million USD | 0.39% |
| 2014 FY | 983 Million USD | -33.36% |
| 2014 Q1 | 208 Million USD | -22.96% |
| 2014 Q2 | 262 Million USD | 25.96% |
| 2013 Q4 | 270 Million USD | -60.84% |
| 2013 Q3 | 689.5 Million USD | 138.83% |
| 2013 FY | 1.47 Billion USD | 22.83% |
| 2013 Q2 | 288.7 Million USD | 27.18% |
| 2013 Q1 | 227 Million USD | -14.34% |
| 2012 FY | 1.2 Billion USD | 20.68% |
| 2012 Q1 | 299.6 Million USD | -7.87% |
| 2012 Q3 | 308.7 Million USD | -7.77% |
| 2012 Q4 | 265 Million USD | -14.16% |
| 2012 Q2 | 334.7 Million USD | 11.72% |
| 2011 Q4 | 325.18 Million USD | 0.96% |
| 2011 FY | 995 Million USD | -23.2% |
| 2011 Q1 | 267 Million USD | -9.25% |
| 2011 Q2 | 316.8 Million USD | 18.65% |
| 2011 Q3 | 322.1 Million USD | 1.67% |
| 2010 Q4 | 294.21 Million USD | -12.64% |
| 2010 FY | 1.29 Billion USD | -4.68% |
| 2010 Q1 | 298.6 Million USD | -9.62% |
| 2010 Q2 | 365.9 Million USD | 22.54% |
| 2010 Q3 | 336.8 Million USD | -7.95% |
| 2009 Q3 | 348.3 Million USD | -3.08% |
| 2009 FY | 1.35 Billion USD | 11.18% |
| 2009 Q4 | 330.39 Million USD | -5.14% |
| 2009 Q1 | 321.06 Million USD | 1.26% |
| 2009 Q2 | 359.37 Million USD | 11.93% |
| 2008 Q4 | 317.05 Million USD | 0.04% |
| 2008 Q1 | 280.26 Million USD | -10.19% |
| 2008 Q2 | 308.12 Million USD | 9.94% |
| 2008 Q3 | 316.93 Million USD | 2.86% |
| 2008 FY | 1.22 Billion USD | 12.01% |
| 2007 FY | 1.09 Billion USD | -3.25% |
| 2007 Q2 | 272.4 Million USD | 35.61% |
| 2007 Q3 | 305.99 Million USD | 12.33% |
| 2007 Q1 | 200.87 Million USD | -28.03% |
| 2007 Q4 | 312.06 Million USD | 1.98% |
| 2006 Q4 | 279.1 Million USD | -4.7% |
| 2006 Q1 | 244.54 Million USD | 4.57% |
| 2006 Q2 | 262.62 Million USD | 7.4% |
| 2006 Q3 | 292.86 Million USD | 11.51% |
| 2006 FY | 1.12 Billion USD | 16.52% |
| 2005 Q2 | 261.2 Million USD | 13.61% |
| 2005 FY | 968.11 Million USD | 7.4% |
| 2005 Q4 | 233.84 Million USD | -3.84% |
| 2005 Q1 | 229.91 Million USD | -0.4% |
| 2005 Q3 | 243.19 Million USD | -6.89% |
| 2004 Q1 | 208.87 Million USD | 6.58% |
| 2004 FY | 901.44 Million USD | 13.33% |
| 2004 Q2 | 230.01 Million USD | 10.12% |
| 2004 Q3 | 231.7 Million USD | 0.73% |
| 2004 Q4 | 230.83 Million USD | -0.37% |
| 2003 FY | 795.43 Million USD | 34.26% |
| 2003 Q4 | 195.98 Million USD | -9.9% |
| 2003 Q3 | 217.52 Million USD | -0.53% |
| 2003 Q2 | 218.68 Million USD | 33.77% |
| 2003 Q1 | 163.47 Million USD | 12.52% |
| 2002 Q2 | 159.66 Million USD | 24.29% |
| 2002 Q1 | 128.46 Million USD | 24.62% |
| 2002 Q3 | 159.02 Million USD | -0.4% |
| 2002 Q4 | 145.28 Million USD | -8.64% |
| 2002 FY | 592.44 Million USD | 44.01% |
| 2001 FY | 411.39 Million USD | 29.44% |
| 2001 Q4 | 103.08 Million USD | -1.95% |
| 2001 Q3 | 105.13 Million USD | -7.44% |
| 2001 Q2 | 113.58 Million USD | 26.79% |
| 2001 Q1 | 89.58 Million USD | 17.13% |
| 2000 FY | 317.81 Million USD | 109.09% |
| 2000 Q4 | 76.48 Million USD | -7.61% |
| 2000 Q3 | 82.78 Million USD | -9.89% |
| 2000 Q1 | 66.66 Million USD | 26.02% |
| 2000 Q2 | 91.87 Million USD | 37.81% |
| 1999 Q2 | 31.5 Million USD | 38.77% |
| 1999 Q1 | 22.7 Million USD | 6.07% |
| 1999 Q4 | 52.9 Million USD | 17.82% |
| 1999 FY | 152 Million USD | 61.19% |
| 1999 Q3 | 44.9 Million USD | 42.54% |
| 1998 Q3 | 21.5 Million USD | -21.53% |
| 1998 Q4 | 21.4 Million USD | -0.47% |
| 1998 FY | 94.3 Million USD | 26.24% |
| 1998 Q2 | 27.4 Million USD | 13.69% |
| 1998 Q1 | 24.1 Million USD | 164.84% |
| 1997 Q2 | 28 Million USD | 48.94% |
| 1997 Q4 | 9.1 Million USD | -51.08% |
| 1997 FY | 74.7 Million USD | 112.42% |
| 1997 Q1 | 18.8 Million USD | 104.1% |
| 1997 Q3 | 18.6 Million USD | -33.57% |
| 1996 Q4 | -459 Million USD | -220.75% |
| 1996 Q3 | -143.1 Million USD | 0.0% |
| 1996 FY | -601.28 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.35 Billion USD | 6.519% |
| Charles River Laboratories International, Inc. | 617.26 Million USD | -104.452% |
| Danaher Corporation | 5.2 Billion USD | 75.74% |
| Enzo Biochem, Inc. | -9.81 Million USD | 12955.251% |
| IQVIA Holdings Inc. | 1.97 Billion USD | 36.166% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -73.925% |
| Mettler-Toledo International Inc. | 1.15 Billion USD | -9.559% |
| Qiagen N.V. | 445.24 Million USD | -183.438% |
| Revvity, Inc. | 300.56 Million USD | -319.88% |
| Thermo Fisher Scientific Inc. | 6.85 Billion USD | 81.601% |
| Waters Corporation | 817.67 Million USD | -54.34% |